Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-22T23:24:39.206Z Has data issue: false hasContentIssue false

Aripiprazole-induced tardive dyskinesia treated with quetiapine: a case report

Published online by Cambridge University Press:  24 June 2014

Nesrin B. Tomruk
Affiliation:
1st Psychiatry Clinic, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey
Omer Saatcioglu
Affiliation:
3rd Psychiatry Clinic, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey Clinic of Early Psychosis, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey
Eren Yildizhan
Affiliation:
1st Psychiatry Clinic, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey
Nihat Alpay
Affiliation:
1st Psychiatry Clinic, Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Turkey

Extract

Tomruk NB, Saatcioglu O, Yildizhan E, Alpay N. Aripiprazole-induced tardive dyskinesia treated with quetiapine: a case report.

Background: Tardive dyskinesia (TD) is a serious, potentially irreversible side effect of antipsychotics. Although the risk is smaller, atypical antipsychotics still pose a risk. Aripiprazole is an atypical antipsychotic with a unique mechanism of action. It has a partial agonistic effect on the presynaptic D2 dopamine autoreceptor and antagonistic effect at postsynaptic D2 receptors.

Method: There have been a few case reports of aripiprazole-induced TD. A case of aripiprazole-induced TD successfully treated with another atypical antipsychotic, quetiapine, is described and discussed in line with the recent literature.

Results: TD showed rapid improvement with discontinuation of aripiprazole and initiation of quetiapine.

Conclusion: Further studies are needed to ascertain the differential effects and side effects of second-generation antipsychotics in terms of TD.

Type
Case Reports
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Correll, CU, Schenk, EM.Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry 2008;21:151156.CrossRefGoogle ScholarPubMed
2.Duggal, HS.Aripiprazole-induced improvement in tardive dyskinesia. Can J Psychiatry 2003;48:771772.CrossRefGoogle ScholarPubMed
3.Maytal, G, Ostacher, M, Stern, TA.Aripiprazole-related tardive dyskinesia. CNS Spectr 2006;11:435439.CrossRefGoogle ScholarPubMed
4.Remington, G.Tardive dyskinesia: Eliminated, forgotten, or overshadowed? Curr Opin Psychiatry 2007;20: 131137.CrossRefGoogle ScholarPubMed
5.Caykoylu, A, Ekinci, O, Kuloglu, M, Deniz, O.Aripiprazole-induced rabbit syndrome: a case report. J Psychopharmacol 2010;24:429431.CrossRefGoogle ScholarPubMed
6.Zaidi, SH, Faruqui, RA.Aripiprazole is associated with early onset of tardive dyskinesia like presentation in a patient with ABI and psychosis. Brain Injury 2008;22:99102.CrossRefGoogle Scholar
7.Abbasian, C, Power, P.A case of aripiprazole and tardive dyskinesia. J Psychopharmacol 2009;23:214215.CrossRefGoogle ScholarPubMed
8.Evcimen, YA, Evcimen, H, Holland, J.Aripiprazole-induced tardive dyskinesia: the role of tamoxifen. Am J Psychiatry 2007;164:14361437.CrossRefGoogle ScholarPubMed
9.Alptekin, K, Kivircik, BB.Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia. Int Clin Psychopharmacol 2002;17:263264.CrossRefGoogle ScholarPubMed
10.Nelson, MW, Reynolds, RR, Kelly, DL, Conley, RR.Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Clin Neuropharmacol 2003;26:297298.CrossRefGoogle Scholar